Germ-line mutations of the p16(INK4)(MTS1) gene occur in a subset of patients with hepatocellular carcinoma

Hepatology

Volumn 25, Issue 6, 1997, Pages 1376-1381

  Chaubert, Pascal ^a   Gayer, René ^b   Zimmermann, Arthur ^b   Fontolliet, Charlotte ^a   Stamm, Bernhard ^c   Bosman, Fred ^a   Shaw, Phillip ^a  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Pathologisches Institut   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P16;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE LOSS; GENE MUTATION; GERM LINE; HEMIZYGOSITY; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; METHYLATION; PRIORITY JOURNAL; SOMATIC MUTATION;

ADULT; AGED; ALLELES; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; EXONS; FEMALE; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); PROTEINS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0030900070     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250613     Document Type: Article

References (17)

1. De Benedetti VM, Welsh JA, Trivers GE, Horpster A, Parkinson AJ, Lanier AP, McMahon BJ. p53 is not mutated in hepatocellular carcinomas from Alaska Natives. Cancer Epidemiol Biomarkers Prev 1995;4:79-82.
2. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-431.
3. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-428.
4. Dumenco L, Oguey D, Wu J, Messier N, Fausto N. Introduction of a murine p53 mutation corresponding to human codon 249 into a murine hepatocyte cell line results in growth advantage, but not in transformation. HEPATOLOGY 1995;22:1279-1288.
5. Challen C, Lunec J, Warren W, Collier J, Bassendine MF. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. HEPATOLOGY 1992;16:1362-1366.
6. Kress S, Jahn UR, Buchmann A, Bannasch P, Schwarz M. p53 mutations in human hepatocellular carcinomas from Germany. Cancer Res 1992;52:3220-3223.
7. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A 1994;91:2230-2234.
8. De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene 1995;10:1725-1729.
9. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 1995;11:447-449.
10. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-707.
11. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1992;258:1148-1152.
12. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH, et al. Germline p16 mutations in familial melanoma. Nat Genet 1994;8:15-21.
13. Spruck CH, Gonzalez-Zulueta M, Shibata A, Simoneau AR, Lin MF, Gonzales F, Tsai YC, et al. p16 gene in uncultured tumours. Nature 1994;370:183-184.
14. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, et al. Frequent somatic mutations and homozygous deletions of the p16(MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.
15. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 1994;54:3396-3397.
16. Zhou X, Tarmin L, Yin J, Jiang HY, Suzuki H, Rhyu MG, Abraham JM, et al. The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene 1994;9:3737-3741.
17. Giani C, Finocchiaro G. Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res 1994;54:6338-6339.